StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright reiterated a buy rating and issued a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.
View Our Latest Analysis on Arcadia Biosciences
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its earnings results on Tuesday, August 13th. The basic materials company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). The firm had revenue of $1.31 million during the quarter, compared to analysts’ expectations of $0.95 million. Arcadia Biosciences had a negative net margin of 127.29% and a negative return on equity of 57.51%. During the same quarter last year, the firm earned ($2.64) EPS. On average, analysts forecast that Arcadia Biosciences will post -1.7 EPS for the current year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Read More
- Five stocks we like better than Arcadia Biosciences
- Investing in Construction Stocks
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- About the Markup Calculator
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- How to Use the MarketBeat Excel Dividend Calculator
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.